Latest Breaking News On - Douglast ross - Page 1 : comparemela.com

History of the HPI: The 2000s: Net-zero, environmental regulations, capacity acceleration and digital transformation

History of the HPI: The 2000s: Net-zero, environmental regulations, capacity acceleration and digital transformation
hydrocarbonprocessing.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hydrocarbonprocessing.com Daily Mail and Mail on Sunday newspapers.

United statesUnited arab emiratesUnited kingdomFrance generalWest virginiaBorough of bedfordPort arthurGulf of omanIran generalAd daw ahNew hampshireRocky mountainAbu dhabiAbuz abySaudi arabiaLaurent fabius

OncoCyte Co (NYSEAMERICAN:OCX) Insider Purchases $21,000 00 in Stock

OncoCyte Co. (NYSEAMERICAN:OCX – Get Rating) insider Douglas T. Ross bought 15,000 shares of OncoCyte stock in a transaction on Friday, March 25th. The stock was acquired at an average price of $1.40 per share, for a total transaction of $21,000.00. The acquisition was disclosed in a legal filing with the SEC, which is accessible […]

United statesDouglast rossPiper sandlerOncocyte coZacks investment researchBlackrock incPenbrook managementCapital partnersNeedham companyOncocyte corporationDefender capitalBroadwood capital incGet ratingInvestment researchCyte corporationNyseamerican ocx

Oncocyte Presents New Data at 2021 American Association for Cancer Research Annual Meeting Demonstrating Potential for Pan-Cancer Utility of DetermaIO™

Message : Required fields Achieved primary endpoint demonstrating significant correlation between DetermaIO and two-year overall survival rate to atezolizumab in metastatic bladder cancer DetermaIO identified additional immunotherapy responsive patients missed by commonly used biomarkers Data supports potential utility of DetermaIO test across multiple solid tumors as predictor of response to Immune Checkpoint Inhibitor therapy in estimated $3 billion market in the United States KOL Webinar discussing results to be held on April 19 at 11:30 AM EDT/8:30 AM PDT IRVINE, Calif., April 10, 2021 (GLOBE NEWSWIRE) Oncocyte Corporation (Nasdaq: OCX), a molecular diagnostics company with a mission to provide actionable answers at critical decision points across the cancer care continuum, presented new data at the American Association for Cancer Research (AACR) Annual Meeting 2021, being held virtually from April 10-15, 2021. The presentations featured studies of Oncocyte’s novel

United statesMamta parikhBrockl schweitzerDouglast rossRobert seitzDoug rossTylerj nielsenOncocyte determaRoberts seitzDavid gandaraDavidr houtBob yedidTerri clevengerLifesci advisorsGenentech incExchange commission

Oncocyte Presents New Data at 2021 American Association for Cancer Research Annual Meeting

Oncocyte Presents New Data at 2021 American Association for Cancer Research Annual Meeting
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

United statesMamta parikhBrockl schweitzerDouglast rossRobert seitzDoug rossTylerj nielsenOncocyte determaRoberts seitzDavid gandaraDavidr houtBob yedidTerri clevengerLifesci advisorsGenentech incExchange commission